Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 24508899)

1.

Treatment of acute uncomplicated cystitis with faropenem for 3 days versus 7 days: multicentre, randomized, open-label, controlled trial.

Hamasuna R, Tanaka K, Hayami H, Yasuda M, Takahashi S, Kobayashi K, Kiyota H, Yamamoto S, Arakawa S, Matsumoto T; Japanese Research Group for UTI (JRGU).

J Antimicrob Chemother. 2014 Jun;69(6):1675-80. doi: 10.1093/jac/dku014. Epub 2014 Feb 6.

PMID:
24508899
2.
3.

Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus.

Hayami H, Takahashi S, Ishikawa K, Yasuda M, Yamamoto S, Uehara S, Hamasuna R, Matsumoto T, Minamitani S, Watanabe A, Iwamoto A, Totsuka K, Kadota J, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Naito S, Tatsugami K, Yamaguchi T, Ito S, Kanokogi M, Narita H, Kawano H, Hosobe T, Takayama K, Sumii T, Fujii A, Sato T, Yamauchi T, Izumitani M, Chokyu H, Ihara H, Akiyama K, Yoshioka M, Uno S, Monden K, Kano M, Kaji S, Kawai S, Ito K, Inatomi H, Nishimura H, Ikuyama T, Nishi S, Takahashi K, Kawano Y, Ishihara S, Tsuneyoshi K, Matsushita S, Yamane T, Hirose T, Fujihiro S, Endo K, Oka Y, Takeyama K, Kimura T, Uemura T.

J Infect Chemother. 2013 Jun;19(3):393-403. doi: 10.1007/s10156-013-0606-9. Epub 2013 May 3.

PMID:
23640203
4.

Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial.

Hooton TM, Roberts PL, Stapleton AE.

JAMA. 2012 Feb 8;307(6):583-9. doi: 10.1001/jama.2012.80.

5.

Efficacy and safety of faropenem in eradication therapy of Helicobacter pylori.

Ogura K, Mitsuno Y, Maeda S, Hirata Y, Yanai A, Shibata W, Ohmae T, Yoshida H, Kawabe T, Omata M.

Helicobacter. 2007 Dec;12(6):618-22.

PMID:
18001403
6.

[Norfloxacine efficacy in acute cystitis in the region with 10% resistance of E. coli to fluoroquinolones: a comparative randomized study].

Rafal'skiń≠ VV, Malev IV, Derevitskiń≠ AV, Kozlov SN, Galkin VV.

Urologiia. 2009 May-Jun;(3):18-21. Russian.

PMID:
19670810
7.

Clinical effects of 2 days of treatment by fosfomycin calcium for acute uncomplicated cystitis in women.

Matsumoto T, Muratani T, Nakahama C, Tomono K.

J Infect Chemother. 2011 Feb;17(1):80-6. doi: 10.1007/s10156-010-0092-2. Epub 2010 Aug 7.

PMID:
20694571
8.

Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis.

Gupta K, Hooton TM, Stamm WE.

J Antimicrob Chemother. 2005 Jul;56(1):243-6. Epub 2005 May 23.

9.

The in-vitro activity of faropenem, a novel oral penem.

Woodcock JM, Andrews JM, Brenwald NP, Ashby JP, Wise R.

J Antimicrob Chemother. 1997 Jan;39(1):35-43.

10.

Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH).

Lim CL, Lee W, Lee AL, Liew LT, Nah SC, Wan CN, Chlebicki MP, Kwa AL.

BMC Infect Dis. 2013 Nov 6;13:523. doi: 10.1186/1471-2334-13-523.

11.

[Detection of beta-lactamase-producing bacteria from female patients with acute uncomplicated cystitis].

Ohkawa M, Yamaguchi K, Orito M, Shimamura M, Hirano S, Hisazumi H.

Hinyokika Kiyo. 1987 Nov;33(11):1800-5. Japanese.

PMID:
3502225
12.

Activity of faropenem against cephalosporin-resistant Enterobacteriaceae.

Mushtaq S, Hope R, Warner M, Livermore DM.

J Antimicrob Chemother. 2007 May;59(5):1025-30. Epub 2007 Mar 12.

13.

Faropenem medoxomil.

Gettig JP, Crank CW, Philbrick AH.

Ann Pharmacother. 2008 Jan;42(1):80-90. Epub 2007 Dec 19. Review.

PMID:
18094341
14.
15.
16.
17.

Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008).

Matsumoto T, Hamasuna R, Ishikawa K, Takahashi S, Yasuda M, Hayami H, Tanaka K, Kiyota H, Muratani T, Monden K, Arakawa S, Yamamoto S.

Int J Antimicrob Agents. 2011 Mar;37(3):210-8. doi: 10.1016/j.ijantimicag.2010.10.032. Epub 2011 Jan 16.

PMID:
21242062
18.

Evaluation of antimicrobial susceptibility for beta-lactams using the Etest method against clinical isolates from 100 medical centers in Japan (2006).

Ishii Y, Tateda K, Yamaguchi K; Japan Antimicrobial Resistance Surveillance Participants Group (JARS).

Diagn Microbiol Infect Dis. 2008 Feb;60(2):177-83. Epub 2007 Oct 10.

PMID:
17931820
19.

Faropenem medoxomil: a treatment option in acute bacterial rhinosinusitis.

Hadley JA, Tillotson GS, Tosiello R, Echols RM.

Expert Rev Anti Infect Ther. 2006 Dec;4(6):923-37. Review.

PMID:
17181408
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk